Why Exact Sciences Stock Is Soaring Today
Investors are reacting positively to the company's Q3 update.
Stay updated with breaking news from Exact Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investors are reacting positively to the company's Q3 update.
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...
Just months after launching a test for guiding immunotherapy, the glycoproteomics firm has switched priorities to a colorectal cancer screening assay.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present new...
These companies aren't handling the downturn well, but they can turn things around.